Stockscreener 앱 받기
67.28
0.93%
-0.63
시간 외 거래:
66.97
-0.31
-0.46%
전일 마감가:
$67.91
열려 있는:
$68.27
하루 거래량:
2.88M
Relative Volume:
1.32
시가총액:
$32.81B
수익:
$10.63B
순이익/손실:
$819.00M
주가수익비율:
40.59
EPS:
1.6577
순현금흐름:
$1.59B
1주 성능:
-3.94%
1개월 성능:
-0.77%
6개월 성능:
-16.80%
1년 성능:
-26.76%
1일 변동 폭
$67.23
$68.37
1주일 범위
$66.17
$68.89
52주 변동 폭
$61.84
$91.61
Alcon Inc Stock (ALC) Company Profile
Compare ALC vs ISRG, BDX, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
67.28 | 33.12B | 10.63B | 819.00M | 1.59B | 1.6577 |
ISRG
Intuitive Surgical Inc
|
356.83 | 120.92B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
158.92 | 43.08B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
39.70 | 32.77B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
203.08 | 28.33B | 5.54B | 1.52B | 1.74B | 10.37 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-26 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2026-01-30 | 개시 | William Blair | Mkt Perform |
| 2026-01-20 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2026-01-09 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-12-11 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2025-08-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-05-20 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-05-14 | 재확인 | BTIG Research | Buy |
| 2025-03-28 | 재확인 | Needham | Buy |
| 2025-03-25 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-01-24 | 재확인 | Needham | Buy |
| 2025-01-10 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | 재확인 | Needham | Buy |
| 2024-11-12 | 재확인 | Needham | Buy |
| 2024-10-10 | 업그레이드 | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2024-04-10 | 개시 | Goldman | Buy |
| 2024-03-14 | 개시 | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | 개시 | Bernstein | Outperform |
| 2023-12-18 | 다운그레이드 | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | 개시 | Stifel | Buy |
| 2023-12-04 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-05-10 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | 업그레이드 | Societe Generale | Sell → Hold |
| 2022-12-22 | 개시 | Mizuho | Buy |
| 2022-11-17 | 다운그레이드 | Societe Generale | Hold → Sell |
| 2022-08-11 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2022-05-13 | 재개 | Credit Suisse | Outperform |
| 2022-05-12 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | 개시 | Needham | Buy |
| 2022-03-11 | 개시 | BofA Securities | Buy |
| 2022-01-18 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | 개시 | Oppenheimer | Perform |
| 2021-07-14 | 개시 | Deutsche Bank | Buy |
| 2021-05-06 | 업그레이드 | Citigroup | Sell → Neutral |
| 2021-03-22 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-11-12 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-07-06 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2020-07-06 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-04-08 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | 업그레이드 | Argus | Hold → Buy |
| 2020-03-24 | 업그레이드 | Societe Generale | Sell → Hold |
| 2020-03-13 | 업그레이드 | UBS | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-26 | 업그레이드 | Berenberg | Hold → Buy |
| 2020-01-08 | 개시 | Argus | Hold |
| 2019-10-29 | 개시 | Stephens | Equal-Weight |
| 2019-08-21 | 재확인 | BofA/Merrill | Neutral |
| 2019-06-24 | 개시 | SVB Leerink | Mkt Perform |
| 2019-06-14 | 개시 | BTIG Research | Neutral |
| 2019-05-10 | 개시 | Robert W. Baird | Outperform |
| 2019-05-02 | 개시 | Credit Suisse | Outperform |
모두보기
Alcon Inc 주식(ALC)의 최신 뉴스
Alcon stock trades steadily as surgical vision business underpins earnings growth - Ad-hoc-news.de
Alcon stock trades steadily as eye-care leader builds on profitable growth and margins - Ad-hoc-news.de
Alcon stock trades steadily as ophthalmic specialist reports higher 2024 revenue and margin improvem - Ad-hoc-news.de
Systane Ultra by Alcon Incdry eye relief anchored in a broad product line - Ad-hoc-news.de
Alcon stock trades steadily as ophthalmic leader focuses on growth and margins - Ad-hoc-news.de
Alcon Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh Revenue Breakdown – BMFBOVESPA:A2LC34 - TradingView
Alcon stock holds as 2025 revenue and margin growth guide the story - Ad-hoc-news.de
Alcon stock trades steadily as eye-care leader posts higher 2024 revenue and margins - Ad-hoc-news.de
Alcon stock trades steadily as earnings and eye care demand support valuation - Ad-hoc-news.de
Alcon stock holds steady as investors await fresh catalyst - AD HOC NEWS
Alcon | 7/24/26 - ktnv.com
Alcon gets you seeing in time for school - WSBT
Alcon: Back-to-School eye exams. What every parent should know. - KHGI
Alcon (ALC) Unveils Advanced Training Center for Vitreoretinal S - GuruFocus
Aravind Eye Care System and Alcon Launch Global Centre of Excellence for Retina Training in Coimbatore, India - PR Newswire
Alcon stock trades steady as eye care specialist builds on 2025 growth and higher margins - Ad-hoc-news.de
Systane Complete by Alcon Inc.dry eye relief built on oil-based drops - AD HOC NEWS
Alcon stock trades steadily as surgical eye care revenue grows - AD HOC NEWS
ALC stock trades steadily as Alcon lifts 2024 outlook on stronger surgical and vision care demand - Ad-hoc-news.de
Enterprise value to revenue forward of Alcon AG – SIX:ALC - TradingView
Alcon stock trades steadily as recent earnings highlight margin and growth mix - Ad-hoc-news.de
Alcon (SWX:ALC) Stock Looks Undervalued On Cash Flow But Fair On Earnings - Yahoo Finance
Alcon stock supported by steady growth and surgical demand - Ad-hoc-news.de
A Look at Alcon Inc (ALC) After 3.8% Decline -- GF Value $91.41 vs Price $67.35 - GuruFocus
ALC|Alcon AG|Price:67.210| - TradingKey
Alcon stock holds its ground as 2025 sales and profit metrics frame the 22 July 2026 setup - Ad-hoc-news.de
Sight Sciences wins $34M patent ruling against Alcon - MSN
The Systane Ultra Lubricant Eye Drops. Dry-eye care with a long shelf presence - Ad-hoc-news.de
Alcon stock trades steady as recent earnings highlight margin and growth dynamics - Ad-hoc-news.de
Alcon stock trades steadily as eye-care leader posts rising revenue and margins - Ad-hoc-news.de
Alcon stock steadies as surgical eye-care demand supports revenue growth - Ad-hoc-news.de
Alcon stock trades steadily as surgical vision business supports earnings - Ad-hoc-news.de
Alcon stock trades steadily as surgical eye-care growth supports earnings - Ad-hoc-news.de
Mexican Gold Mining Corp. and Alcon Silver Corp. Complete Arrangement to Create Platauro Metals Corp., a Diversified Precious Metals Exploration Company - TMX Newsfile
Alcon Inc. (ALC) Stock Analysis: Navigating 24.66% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Alcon stock trades steadily as surgical eye care growth supports earnings outlook - Ad-hoc-news.de
Price to book forward of Alcon AG – BX:2U3 - TradingView
Alcon stock trades steadily as eye-care demand supports revenue growth - Ad-hoc-news.de
Alcon stock trades near recent highs as surgical vision demand supports growth - Ad-hoc-news.de
Alcon stock trades steadily as eye care group highlights Q1 2026 growth and margins - Ad-hoc-news.de
Alcon stock trades steadily as eye care leader builds on solid revenue growth - Ad-hoc-news.de
Alcon stock steadies as investors weigh surgical vision growth and recent earnings trends - Ad-hoc-news.de
Alcon stock trades steady as eye-care margins support growth outlook - Ad-hoc-news.de
Alcon stock trades steadily as surgical eye care growth supports margins - ad-hoc-news.de
Systane Augentropfen by Alcon Inc.dry-eye relief built on medical data - ad-hoc-news.de
Alcon stock trades steady as vision care group focuses on margin and growth after 2025 earnings - Ad-hoc-news.de
Alcon stock trades steadily as surgical eye care growth supports recent earnings - ad-hoc-news.de
Alcon stock trades steady as latest earnings show margin resilience - ad-hoc-news.de
Mizuho Securities Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $80 - Moomoo
Alcon stock holds steady as eye-care demand supports the long-term growth story - ad-hoc-news.de
Systane Hydration by Alcon Inc.dry eye relief beyond the pharmacy shelf - ad-hoc-news.de
Alcon Inc (ALC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.45%
자본화:
|
볼륨(24시간):